PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of ayuHomeCurrent issueInstructionsSubmit article
 
Ayu. 2012 Jan-Mar; 33(1): 50–53.
PMCID: PMC3456864
Effect of Kshara Basti and Nirgundi Ghana Vati on Amavata (Rheumatoid Arthritis)
Krishna Thanki, Nilesh Bhatt,1 and V. D. Shukla2
Deputed Lecturer, Department of Panchakarma, Government Ayurved College, Junagadh, India
1Panchakarma Physician, Department of Panchakarma, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India
2Professor and Head, Department of Kaya Chikitsa, JS Ayurved Mahavidyalaya, Nadiad, Gujarat, India
Address for correspondence: Dr. Krishna Thanki, D-2, BSNL Staff Quarters, Near Panjra Pol, Krishna Nagar, Main Road, Jamnagar - 361 006, Gujarat, India. E-mail: khthanki/at/yahoo.co.in
Ayurveda has taken the foremost place in the management of crippling disease, one of them is Amavata which can be compared with Rheumatoid Arthritis due to its clinical appearance. Due to wide spectrum of disease, much prevalence in the society and lack of effective medicament, the disease is being chosen for the study. The line of treatment described for the disease in Chakradatta can be summarized under following captions. i.e to bring Agni to normal state to digest Ama, and eliminate vitiated Vata and Ama. Thus, here Kshara Basti is selected for the present study as Samshodhana process which corrects all of above captions. It is mentioned in Chikitsa Sutra described by Chakradatta. Nirgundi has Amavatahara property which is stated by Bhavaprakasha, considering which Nirgundi Patra Ghanavati is selected as Shamana drug. Total 50 randomly selected patients of Amavata were registered among them 45 were completed the treatment. Kshara Basti in the format of Kala Basti was given to these patients and Nirgundi Ghana Vati was given for one month. Statistically significant improvement was found in ESR, RA factor (quantitative) and also highly significant results were found in symptoms of Amavata. Moderate improvement was seen in 40% of patients, 35.56% patients got marked improvement, while mild improvement was found in 24.44% of patients.
Keywords: Amavata, Kshara Basti, Nirgundi Ghana Vati, Rheumatoid Arthritis
In present time, due to modern life style, hectic schedule, stress, and many such reasons, incidence of diseases are increasing, one of them is Amavata. The concept of autoimmunity is well-explained under the concept of Ama, an intermediate product generated due to the deranged metabolism of digestive fire triggering a chronic inflammatory process in the body. Rheumatoid arthritis is a chronic inflammatory disease. In the whole world, rheumatic disease is the most common cause of physical impairment in society. The lives of more than one million people are physically impaired by rheumatic disorders and one fifth of these are severely disabled. The prevalence rate of this disease is about 3% with a male to female ratio of 1:3.[1] It occurs throughout the world in all climates and ethnic groups. Till date, about 39 Research activities have been carried out in P.G. Institute, Jamnagar. Previously in Jamnagar, eight activities have been done on Basti, while nine on Virechana Karma, and only three on Kshara Basti. This number itself suggests its large occurrence and faith of patients in Ayurvedic Management. Only three research activities had been done on Kshara Basti in Jamanagar.[2]
Shodhana (bio-purification), Shamana (pacification) and Nidana Parivarjanam are main modalities of treatment for any disease.[3] So, in the present study, Kshara Basti has been selected as Shodhana Chikitsa which is mentioned in Chikitsa Sutra described by Chakradatta[4] and Nirgundi Ghana Vati has been selected as Shamana Chikitsa.
Aims and Objectives
  • To evaluate the efficacy of “Kshara Basti along with Nirgundi Ghana Vati” on Amavata.
  • To evaluate the efficacy of Kshara Basti along with Nirgundi Ghana Vati on Heamatological and Bio chemical parameters especially ESR and R.A. Factor (quantitative)test.
Total 50 patients fulfilled criteria for diagnosis of the disease Amavata (Rheumatoid Arthritis) were selected from the O.P.D. and I.P.D. of Panchakarma Department of I.P.G.T. and R.A., Jamnagar. This study was approved by Institutional Ethics Committee.
Inclusion criteria
  • Patients having classical features of Amavata like Angamarda, Aruchi, Trishna, Hrillasa, Gaurava, Jwara, Shula, Shotha etc.[5] were selected for the present clinical research work. Detailed research proforma was prepared incorporating all the clinical features seen in the disease Amavata (Rheumatoid Arthritis).
  • The patients who had fulfilled the revised criteria for Rheumatoid arthritis fixed by the American college of Rheumatology in 1987.[6]
Rheumatoid factor positive and negative both cases were included.
Exclusion criteria
  • Chronicity of more than 10 years
  • Having severe crippling deformity
  • Having cardiac disease, pulmonary tuberculosis and pregnant women
  • Age less than 18 years and more than 60 years
Plan of study
The selected patients were given Kshara Basti along with Eranda Taila Anuvasana Basti in format of Kala Basti[7] i.e., 16 days.
  • Deepana, Pachana with Shunthi Churna for three days
  • Sarvanga Nirgundi Patra Pinda Sweda before giving Basti
  • After completing Basti, Nirgundi Ghana Vati 2 tab (500 mg/tab) thrice a day for 30 days. Nirgundi Ghana Vati is prepared from Nirgundi Patra Kwatha
Total Duration: 46 days.
Laboratory investigations
  • Rheumatoid Factor (Quantitative) test
  • Erythrocyte Sedimentation Rate by Westergren method
  • Serum uric acid (for exclusion)
  • X-ray of the affected joint
  • Routine urine, blood examination
Criteria for assessment
The results of therapy were assessed on the basis of clinical features of the disease Amavata, which are mentioned in Ayurvedic classic as well as with the help of criteria fixed by American Rheumatism Association in 1987. The scoring pattern adopted for assessment of clinical features is as follows:
An external file that holds a picture, illustration, etc.
Object name is Ayu-33-50-g001.jpg
Effect of therapy on chief complaints such as Sandhishoola, Sandhishotha, Sandhistabdhata and Sandhisparsa Asahyata is found to be statistically highly significant (P>0.001) [Table 1]. Also statistically highly significant (P>0.001) results were found on general symptoms such as Angamarda, Aruchi, etc.; associated symptoms such as Daurbalya, Agnimandya, Praseka, etc. and on functional capacity parameters [Tables [Tables224].
Table 1
Table 1
Effect on chief complaints
Table 2
Table 2
Effect on general symptoms
Table 4
Table 4
Effect on functional capacity
Table 3
Table 3
Effect on associated symptoms
The retention time of Kshara Basti upto 5mins was observed in maximum number of patients (60%) and retention time of Anuvasana Basti - 3 to 6 hrs was observed in 62.22% patients [Tables [Tables55566].
Table 5
Table 5
Effect on ESR
Table 6
Table 6
Effect on rheumatoid factor
The effect of therapy on Erythrocyte sedimentation rate and RA factor (Quantitave) was found to be statistically highly significant (P>0.001)and significant(P>0.01) respectively [Tables [Tables77788].
Table 7
Table 7
Retention time of Kshara Basti
Table 8
Table 8
Retention time of Anuvasana Basti
In overall effect of therapy maximum number of patients (40%) got moderate improvement [Chart 1].
Chart 1
Chart 1
Overall effect of therapy
Maximum number of patients (40%) belonged to the age group of 41-50 years, which shows its predominance in the middle age group. This data is slightly in accordance with the modern findings, that the onset is most frequent during the fourth and fifth decades of life with 80% of all patients developing disease between the age of 35 and 50 years. In this study, majority of the patients were female (91.11%) as compared to male. Textual references also reflect the predominance of rheumatoid arthritis in females. Majority of the patients were having Mandagni (97.77%). Mandagni is the root of all the disease, particularly of Amavata. In the present study, majority of the patients had Madhyama (46.66%) and Krura Kostha (57.77%). It justifies the finding of Prakriti. The study reveals that maximum number of patients possesses Vata Pitta Prakriti i.e., 48.88%. According to Acharya Vagabhata, Dwidoshaja Prakriti is Nindya, Hemadri gives commentary on that Vata-Pitta Prakriti is Hinatama, persons who having this Prakriti, are more prone to disease.[8] Maximum numbers of patients were having history of gradual onset (86%) and chronicity of <2 years (51%). The disease runs a chronic course and also becomes chronic due to the non-availability of good treatment in contemporary medicine. It may be due to the fact that Amavata is a chronic disease and usually manifests itself over a period of a few months. Most of the patients were found to be indulged in Viruddha Ahara (93%), Atiguru (63%), Visamashana (42%), Snigdha Ahara (40%), Divasvapna (66%), Nischalatva (55%), Bhojanottara Vyayama (31%), Chinta (69%). All these factors lead to Mandagni and consequently to formation of Ama. So, it can be concluded that all the above mentioned factors play an important role in precipitation and aggravation of the disease Amavata. These data also support the etiology of Amavata, mentioned in classics. Kshara Basti comprises of Saindhava, Guda, Chincha, Shatahva and Gomutra. In this Basti, maximum quantity is of Gomutra, which is having Kshara Guna. Kshara has the property of Lekhana and Vishoshana,[9] which are antagonistic to Ama and is very much required in the conditions like Amavata. But it must be kept in the mind that, it may further vitiate Vata. Thus, keeping this view in mind Eranda Taila Anuvasana was given in the format of Kala Basti. Eranda has a typical property of Ama Pachana.[10] Chincha to be taken in Kshara Basti should be in Pakva stage that is having Vata-Kapha Shamaka[11] property. Regarding Purana Guda to be used, it is Laghu, Pathya, Annabhishyandi, Agnivardhaka and Vata-Pittaghna.[12] Saindhava due to its Sukshma and Tikshna[13] property helps the Basti Dravya to reach up to the molecular level. It is capable of liquefying the viscid matter and breaking it into minute particles. Thus solves both the purpose; to curing the disease and to purify the body. Nirgundi Ghana Vati, which was given after Basti has a definite action on vitiated Vata Kapha Dosha. Specially, Tikta and Katu Rasa present in Nirgundi possess the antagonistic properties to that of Ama and Kapha which are the chief causative factors in this disease. Because of their Agnivriddhikara property they increase digestive power which also digests Amarasa and reduces excessive production of Kapha and also removes the obstruction of the Srotas. Because of Tikshna Guna and Ushna Virya it also alleviates vitiated Vata and reduces Srotorodha and pain. Thus Nirgundi controls Ama and Vata together and minimize the process of pathogenesis. Chincha, Gomutra, Shatahva, Nirgundi have anti-oxidant and anti-inflammatory properties, which reduces inflammatory process in the body.
Conclusion
Lastly, it can be concluded that Amavata looks similar to Rheumatoid Arthritis in its clinical appearance and Kshara Basti along with Nirgundi Ghana Vati is effective in the treatment of Amavata. Also, it gives significant results on rheumatoid factor and highly significant result on ESR which is used for diagnosis of rheumatoid arthritis.
1. Braunwald, editor. Harrison's Principles of Internal Medicine. 15th ed. Part 12. Vol. 2. New York: McGraw Hill organization; 2001. p. 1928.
2. Baghel MS. Researches in Ayurveda. 2nd ed. Jamnagar: Mridu Ayurveda Publication and Sales; 2005.
3. Sharma Yadav., editor. Vimanasthana 8-30. New Delhi: Rashtriya Sanskrita Samsthana; 1984. Charaka Samhita Ayurvedadipikavyakhya; p. 261.
4. Tripathi Indradev., editor. Amavata Chikitsa. 4th ed. Varanasi: Chaukhambha Sanskrit Sanasthana; 2002. Chakradatta. Savimarsha vaidyaprabha hindi vyakhya; p. 166.
5. Parmar Dayal., editor. Amavata Nidana Sloka. Ahmedabad: Sarsvati Pustaka Bhandara; 1994. Madhava Nidana. Madhukoshavyakhya; p. 683.
6. Braunwald, editor. Harrison's Principles of internal medicine. 15th ed. Part 12. Vol. 2. New York: Mc Graw Hill organization; p. 1934.
7. Sharma Yadav., editor. Siddhisthana 1-48. New Delhi: Rashtriya Sanskrita Samsthana; 1984. Charaka Samhita. Ayurvedadipikavyakhya; p. 684.
8. Sharma Ram Prasad., editor. Sutrasthana 1-13. Mumbai: Khemraj Shrikrishnadas; 1928. Ashtanghridaya. Commentary of Hemadri, Sarwangasundara, Padarth Chandrika and Ayurvedarasayan commentaries; p. 15.
9. Sharma Yadav., editor. Vimanasthana 1-17. New Delhi: Rashtriya Sanskrita Samsthana; 1984. Charaka Samhita. Ayurvedadipikavyakhya; p. 234.
10. Shashtri Girijashankar Mayashankara., editor. Bhavamishravirachita. Mumbai: Sastu Sahitya; 1966. Bhavaprakasha Purvakhanda, (Bhavaprakasha Nighntu) p. 543. Chapter 19-24.
11. Sharma Yadav., editor. Sutrasthana 27-151. New Delhi: Rashtriya Sanskrita Samsthana; 1984. Charaka Samhita. Ayurvedadipikavyakhya; p. 161.
12. Shashtri Girijashankar Mayashankara., editor. Bhavamishravirachita. Mumbai: Sastu Sahitya; 1966. Bhavaprakasha Purvakhanda, (Bhavaprakasha Nighntu) p. 556. Chapter 22-26.
13. Shashtri Girijashankar Mayashankara., editor. Bhavamishravirachita. Mumbai: Sastu Sahitya; Bhavaprakasha Purvakhanda, (Bhavaprakasha Nighntu) p. 234. Chapter 1-223.
Articles from Ayu are provided here courtesy of
Medknow Publications